AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Union (EU) for the treatment of adult patients with previously ...

AstraZeneca announced on Monday that it secured a US regulatory approval and a positive EU recommendation for two of its ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

Wojciech Jurczak, MD, PhD, discusses advancements in B-cell lymphoma therapy, focusing on immunotherapy, molecular-targeted agents, and more.

Mantle cell lymphoma tends to grow quickly. When doctors find this type of cancer, it’s usually widespread throughout your body already. This can make treatment more difficult. But doctors have ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

London stocks were set to fall at the open on Monday following heavy losses in Asia, with Donald Trump’s tariffs due to kick ...

(Alliance News) - AstraZeneca PLC on Monday detailed progress with two of its drugs as it reported an endorsement in the EU and an approval in the US.

This type affects 1 in 20 people with lymphoma and is more common in older adults and men. It forms in your spleen, lymph nodes, or bone marrow. Mantle cell lymphoma grows slowly but can be hard ...

The main types of blood cancer are: Mantle cell lymphoma (MCL) is one of 70 subtypes of non-Hodgkin’s lymphoma that starts in the bone marrow, where blood cells are made, although cancerous ...